期刊文献+

A New Triterpenoid Saponin from Aidi Injection

A New Triterpenoid Saponin from Aidi Injection
原文传递
导出
摘要 Objective To investigate the chemical constituents from Aidi Injection.Methods The chemical constituents were isolated by chromatography on Sephadex LH-20 gel columns and reverse phase semi-preparative HPLC repeatedly.Their structures were identified by spectroscopic analysis(NMR and MS).Results Twenty-two compounds were isolated and identified to be 3-O-3′,4′-diacetyl-β-D-xylopyranosyl-6-O-β-D-glucopyranosyl- cycloastragenol(1),astragaloside IV(2),astragaloside II(3),astragaloside I(4),isoastragaloside I(5), acetylastragaloside I(6),ginsenosid Re(7),ginsenoside Rf(8),ginsenoside Rg1(9),ginsenoside Rb3(10), notoginsenoside R4(11),ginsenoside Rb1(12),ginsenoside Rc(13),ginsenoside Rb2(14),ginsenoside Rd(15), lucyoside H(16),3-O-β-D-glucopyranosyl(1→4)-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L- arabinopyranosyl oleanolic acid 28-O-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside (17),3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl[β-D-glucopyranosyl-(1→4)]-(1→2)-α-L-arabinopyranosyl oleanolic acid 28-O-α-L-arabinopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside(18),syringin (19),elentheroside E(20),4-(1,2,3-trihydroxypropyl)-2,6-dimethoxyphenyl-1-O-β-D-glucopyranoside(21),and coniferin(22).Conclusion Compounds 1-6 are originated from Astragalus membranceus,compounds 7-18 are originated from Panax ginseng,and compounds 19-22 are originated from Acanthopanax senticosus by LC-MS analysis.Compound 1 is a new compound. Objective To investigate the chemical constituents from Aidi Injection.Methods The chemical constituents were isolated by chromatography on Sephadex LH-20 gel columns and reverse phase semi-preparative HPLC repeatedly.Their structures were identified by spectroscopic analysis(NMR and MS).Results Twenty-two compounds were isolated and identified to be 3-O-3′,4′-diacetyl-β-D-xylopyranosyl-6-O-β-D-glucopyranosyl- cycloastragenol(1),astragaloside IV(2),astragaloside II(3),astragaloside I(4),isoastragaloside I(5), acetylastragaloside I(6),ginsenosid Re(7),ginsenoside Rf(8),ginsenoside Rg1(9),ginsenoside Rb3(10), notoginsenoside R4(11),ginsenoside Rb1(12),ginsenoside Rc(13),ginsenoside Rb2(14),ginsenoside Rd(15), lucyoside H(16),3-O-β-D-glucopyranosyl(1→4)-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L- arabinopyranosyl oleanolic acid 28-O-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside (17),3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl[β-D-glucopyranosyl-(1→4)]-(1→2)-α-L-arabinopyranosyl oleanolic acid 28-O-α-L-arabinopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside(18),syringin (19),elentheroside E(20),4-(1,2,3-trihydroxypropyl)-2,6-dimethoxyphenyl-1-O-β-D-glucopyranoside(21),and coniferin(22).Conclusion Compounds 1-6 are originated from Astragalus membranceus,compounds 7-18 are originated from Panax ginseng,and compounds 19-22 are originated from Acanthopanax senticosus by LC-MS analysis.Compound 1 is a new compound.
机构地区 College of Pharmacy
出处 《Chinese Herbal Medicines》 CAS 2012年第2期84-86,共3页 中草药(英文版)
基金 National Technology Research Program for Creating New Drugs (2009ZX09308-003 and 2011ZX09201-201-16)
关键词 Aidi Injection astragaloside I astragaloside II astragaloside IV 3-O-3′ 4′-diacetyl-β-D-xylopyranosyl-6-O-β-D- glucopyranosyl-cycloastragenol Aidi Injection astragaloside I astragaloside II astragaloside IV 3-O-3′,4′-diacetyl-β-D-xylopyranosyl-6-O-β-D- glucopyranosyl-cycloastragenol
  • 相关文献

参考文献6

二级参考文献30

  • 1徐先祥,彭代银,刘青云.黄芪皂甙类成分对心血管系统的作用(综述)[J].北京中医药大学学报,2000,23(S1):128-130. 被引量:29
  • 2杨骅,王仙平,郁琳琳,郑树.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志,1996,18(3):169-172. 被引量:229
  • 3MASYUKI Y, WANG H K, HIROSHI K, Saponin and sapogenol. XL[J]. Chem Pharm Bull, 1985, 33 (10) :4267 - 4274.
  • 4KITAGAWA I, WANG H K, TAKAGI A, et al. Saponin and sapogenol. XXXIV-XXXVII [J]. Chem Pharm Bull, 1983, 31(2) :689 - 722.
  • 5Chang Y D, Charles H P, John M P, et al. Plant anticancer agents XL I . Cytotoxic constituents from Wikstroemla elliptica [J]. J Nat Prod, 1986, 49(4): 706-709.
  • 6Kizu H, Shimana H, Tomimori T, et al. Studies on the constituents of clematis species VI. The constituents of Clematis stans Sieb. et Zucc. [J]. Chem Pharm Bull, 1995, 43(12):2187-2194.
  • 7Gamal A A E, Takeya K, Itokawa H, et al. Lignan bis-glucosides from Galium sinaicum [J]. Phytochemistry, 1997, 45(3): 597-600.
  • 8WangM S.Studies on the constituents of Daphne giraldii Nitsche ( Ⅱ) .中草药,1980,11(19):389-390.
  • 9中华人民共和国卫生部制定发布.中药新药临床研究指导原则第1辑[Z].,1993.158-162.
  • 10Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer trearment. Cancer 1981;47(1):207-214.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部